The Malaysian Reserve

NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem’s Shares

The final exchange ratio is 7.06 NLS common shares for each Kadimastem ordinary share. Following the implementation of the ...